Immunotherapy drug combination stimulates immune system against resistant cancers 22 Aug 2022 A combination treatment of immunotherapy with the experimental drug guadecitabine may reverse a cancer’s resistance to immunotherapy – making it sensitive to treatment again, a new study has found. Find out more Show/Hide
AI study 'exciting first step' towards improving post-treatment surveillance of lung cancer patients 23 Apr 2022 Artificial intelligence (AI) could help guide the post-treatment surveillance of non-small cell lung cancer (NSCLC) patients and improve outcomes as a result, according to new research. Find out more Show/Hide